SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-006678
Filing Date
2017-11-07
Accepted
2017-11-07 08:01:51
Documents
49
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_110817p.htm 10-Q 777990
2 EXHIBIT 10.2 exh_102.htm EX-10.2 113414
3 EXHIBIT 31.1 exh_311.htm EX-31.1 9219
4 EXHIBIT 31.2 exh_312.htm EX-31.2 9004
5 EXHIBIT 32.1 exh_321.htm EX-32.1 6613
12 GRAPHIC exh102a.jpg GRAPHIC 99812
  Complete submission text file 0001171843-17-006678.txt   2951008

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prto-20170930.xml EX-101.INS 338266
7 XBRL SCHEMA FILE prto-20170930.xsd EX-101.SCH 30856
8 XBRL CALCULATION FILE prto-20170930_cal.xml EX-101.CAL 25085
9 XBRL DEFINITION FILE prto-20170930_def.xml EX-101.DEF 214157
10 XBRL LABEL FILE prto-20170930_lab.xml EX-101.LAB 188102
11 XBRL PRESENTATION FILE prto-20170930_pre.xml EX-101.PRE 228892
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36694 | Film No.: 171181161
SIC: 2836 Biological Products, (No Diagnostic Substances)